Literature DB >> 17923481

Pyruvate dehydrogenase complex deficiency caused by ubiquitination and proteasome-mediated degradation of the E1 subunit.

Zongchao Han1, Li Zhong1, Arun Srivastava2, Peter W Stacpoole3.   

Abstract

Congenital deficiencies of the human pyruvate dehydrogenase (PDH) complex are considered to be due to loss of function mutations in one of the component enzymes. Here we describe a case of PDH deficiency associated with the PDH E1beta subunit (PDHB) gene. The clinical phenotype of the patient was consistent with reported cases of PDH deficiency. Cultured skin fibroblasts demonstrated a 55% reduction in PDH activity and markedly decreased immunoreactivity for PDHB protein, compared with healthy controls. Surprisingly, nucleotide sequence analyses of cDNAs corresponding to the patient PDH E1alpha (PDHA1) and PDHB genes revealed no pathological mutations. Moreover, the relative expression level of PDHB mRNA and the rates of transcription and translation of the PDHB gene were normal. However, PDC activity could be restored in cells from this patient following treatment with MG132, a specific proteasome inhibitor, and normal levels of E1beta could be detected in MG132-treated cells. Similar results were obtained following treatment with Tyr-phostin 23 (Tyr23), a specific inhibitor of epidermal growth factor receptor-protein-tyrosine kinase (EGFR-PTK), which also restored E1beta protein levels to those in cells from healthy subjects or from patients with PDHA1 deficiency. The index patient's cells contained a high basal level of EGFR-PTK activity that correlated with the high level of ubiquitination of cellular proteins, although the total EGFR protein levels were similar to those in cells from Elalpha-deficient subjects and healthy subjects. These data indicate that PDH deficiency in our patient involves a post-translational modification in which EGFR-PTK-mediated tyrosine phosphorylation of the E1beta protein leads to enhanced ubiquitination followed by proteasome-mediated degradation. They also provide a novel mechanism accounting for congenital deficiency of the PDH complex and perhaps other inborn errors of metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923481     DOI: 10.1074/jbc.M704748200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 β subunit.

Authors:  Atsuhiro Kanda; Kousuke Noda; Susumu Ishida
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

3.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

4.  An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α.

Authors:  Carolyn Ojano-Dirain; Lyudmyla G Glushakova; Li Zhong; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2010-07-15       Impact factor: 4.797

5.  NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.

Authors:  Jun Xu; Feng Chi; Tongsheng Guo; Vasu Punj; W N Paul Lee; Samuel W French; Hidekazu Tsukamoto
Journal:  J Clin Invest       Date:  2015-03-23       Impact factor: 14.808

6.  System analysis of an Arabidopsis mutant altered in de novo fatty acid synthesis reveals diverse changes in seed composition and metabolism.

Authors:  Mingjie Chen; Brian P Mooney; Martin Hajduch; Trupti Joshi; Mingyi Zhou; Dong Xu; Jay J Thelen
Journal:  Plant Physiol       Date:  2009-03-11       Impact factor: 8.340

7.  PDH E1β deficiency with novel mutations in two patients with Leigh syndrome.

Authors:  E Quintana; J A Mayr; M T García Silva; A Font; M A Tortoledo; S Moliner; L Ozaez; M Lluch; A Cabello; J R Ricoy; J Koch; A Ribes; W Sperl; P Briones
Journal:  J Inherit Metab Dis       Date:  2009-11-09       Impact factor: 4.982

8.  Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human.

Authors:  Ding Wang; Caiyun Fang; Nobel C Zong; David A Liem; Martin Cadeiras; Sarah B Scruggs; Hongxiu Yu; Allen K Kim; Pengyuan Yang; Mario Deng; Haojie Lu; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2013-09-15       Impact factor: 5.911

9.  Phenylbutyrate therapy for pyruvate dehydrogenase complex deficiency and lactic acidosis.

Authors:  Rosa Ferriero; Giuseppe Manco; Eleonora Lamantea; Edoardo Nusco; Maria I Ferrante; Paolo Sordino; Peter W Stacpoole; Brendan Lee; Massimo Zeviani; Nicola Brunetti-Pierri
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

10.  Loss of the transcriptional repressor Rev-erbα upregulates metabolism and proliferation in cultured mouse embryonic fibroblasts.

Authors:  Sean P Gillis; Hongwei Yao; Salu Rizal; Hajime Maeda; Julia Chang; Phyllis A Dennery
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.